The World Health Organization issued new guidance this week on the use of popular GLP-1 drugs, like Ozempic, Wegovy, Mounjaro ...
GLP-1 medicines cause malnutrition in 22% of patients. Multivitamins are often inadequate. Patients need dietitian support ...
Researchers have developed a new oral drug that boosts metabolic activity in muscle rather than altering appetite like GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback